Research Feed
Latest FDA updates, clinical trials, and safety alerts for catalogued peptides
2 Critical5 Important
🏛️
FDA Updateimportant2026-06-15
FDA Approves Zepbound (Tirzepatide) for Obesity
Tirzepatide·FDA
📄
New Studyinformational2026-05-20
BPC-157 Systematic Review: Regeneration to Analgesia
BPC-157·PubMed
⚠️
Safety Alertcritical2026-04-10
GLP-1 RA Class Warning: Gallbladder Events
Semaglutide·FDA MedWatch
🔬
Clinical Trialimportant2026-03-28
Phase 2 Trial: Oral Semaglutide 50mg for Obesity
Semaglutide·ClinicalTrials.gov
📄
New Studyinformational2026-03-15
Thymosin Alpha-1 in Chronic Hepatitis B: Meta-Analysis
Thymosin Alpha-1·PubMed
📋
Label Changecritical2026-02-20
Wegovy Label Update: Cardiovascular Outcomes
Semaglutide·FDA
📄
New Studyinformational2026-02-10
GHK-Cu Topical for Diabetic Wound Healing
GHK-Cu·PubMed
⚠️
Safety Alertimportant2026-01-25
GH Secretagogues: Carpal Tunnel Syndrome Risk
CJC-1295·EMA
🔬
Clinical Trialimportant2026-01-10
Phase 1: BPC-157 for IBD — First Human Data
BPC-157·ClinicalTrials.gov
📄
New Studyinformational2025-12-15
Cerebrolysin for Post-Stroke Recovery: Cochrane Review
Cerebrolysin·Cochrane Library
🏛️
FDA Updateimportant2025-11-30
Vyleesi (Bremelanotide) REMS Program Updated
Bremelanotide·FDA
📄
New Studyinformational2025-11-15
Tesamorelin for NAFLD: Phase 2 Results
Tesamorelin·PubMed